World-First Human Trial Offers New Type 1 Diabetes Treatment
St Vincent’s Institute of Medical Research
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
Heart Disease
SARS-CoV-2 Can Infect Arteries and Worsen Plaque Inflammation
National Institutes of Health
Latest study explores the link between COVID-19 infection and increased risk of cardiovascular disease and stroke
IL-1 Receptor Blocker Doesn’t Reduce Myocarditis Complications
European Society of Cardiology
Anakinra treatment didn’t show a significant spike in the number of days free of myocarditis in the largest randomized controlled trial
Genetic Risks for SCAD Affecting Younger Women Revealed
University Hospitals of Leicester NHS Trust
First international genome-wide association meta-analysis identifies 16 genes that exacerbate SCAD risk
Younger Women at Greater Risk of Rehospitalization after Heart Attacks
Swathi Kodaikal, MSc
Women’s health demands attention and intervention—more than ever before—to better understand the impact of various stressors
Daily Statin Dose May Reduce CVD Risk in HIV Patients
National Institutes of Health
Per Data Safety and Monitoring Board, the benefits of using pitavastatin daily outweighed any risks
Oral Bacteria May Slightly Increase Heart Disease Risk
eLife
Further research will provide insight into how bacterial infections may affect heart health
Clinicians Call for Accurate Characterization of Heart Muscle Disorders
Queen Mary University of London
Deeper research, genetic tools may help better understand and treat excessive trabeculation
Low-Grade Inflammation May Cause Arterial Stiffness in Adolescents
University of Eastern Finland
Food and lifestyle in children and young adults may trigger premature vascular damage
Clinical Trial to Study Treatment for Acute Heart Attack Complications
Indiana University School of Medicine
The new clinical trial has seen its first patient enrolled this month